StocksMedium•10 November 2026•
1 min read
Sionna Therapeutics Shares Under Pressure After Wider-Than-Expected Q3 Loss
Key Facts
1Sionna Therapeutics reported a GAAP EPS of -$0.72, missing analyst estimates by $0.09.
Sionna Therapeutics reported a GAAP loss per share of $0.72 for the third quarter of 2026. Seeking Alpha reported that the result missed analyst estimates by $0.09, representing a wider-than-anticipated loss for the period.
SION closed at $3.57 on November 9, 2026, prior to the release of results showing a cash position of $249.8 million as of September 30, 2026. The company stated that this capital is expected to fund its operations into the second half of 2029.